Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 8,081 | 9,175 | 6,177 | 5,583 | 5,541 |
| Cost of Goods | 1,630 | 1,950 | -3,440 | 1,730 | 1,280 |
| Gross Profit | 6,440 | 7,220 | 5,860 | 3,840 | 4,250 |
| Operating Expenses | 11,660 | 11,590 | 34,010 | 10,330 | 10,280 |
| Operating Income | -4,579 | -3,415 | -24,833 | -5,747 | -5,739 |
| Interest Expense | 1,070 | 150 | 2,570 | 10 | 2,010 |
| Other Income | -15,151 | -25,865 | 24,093 | -1,833 | -28,811 |
| Pre-tax Income | -20,800 | -29,430 | -3,310 | -7,590 | -36,560 |
| Income Tax | 270 | -2,790 | -4,860 | -1,220 | -3,700 |
| Net Income Continuous | -21,073 | -26,638 | 5,126 | -6,369 | -32,854 |
| Net Income | $-21,073 | $-26,638 | $5,126 | $-6,369 | $-32,854 |
| EPS Basic Total Ops | -0.55 | -0.94 | 0.20 | -0.25 | -1.29 |
| EPS Basic Continuous Ops | -0.55 | -0.94 | 0.20 | -0.25 | -1.29 |
| EPS Diluted Total Ops | -0.55 | -0.94 | 0.20 | -0.25 | -1.29 |
| EPS Diluted Continuous Ops | -0.55 | -0.94 | 0.20 | -0.25 | -1.29 |
| EBITDA(a) | $-939 | $155 | $-24,113 | $-4,987 | $-4,979 |